12:00 AM
 | 
Jan 28, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Ariad completes follow-on

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Cambridge, Mass.
Business: Cancer
Date completed: 1/24/13
Type: Follow-on...

Read the full 42 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >